BDC Healthcare Venture logo

BDC Healthcare Venture

North America, Quebec, Canada, Montréal

Description

The Healthcare Venture Fund invests in transformative Canadian companies working to increase healthcare productivity.

Investor Profile

BDC Healthcare Venture has made 11 investments, with 0 in the past 12 months and 36% as lead.

Stage Focus

  • Series A (45%)
  • Series B (36%)
  • Series Unknown (9%)
  • Series D (9%)

Country Focus

  • Canada (91%)
  • United States (9%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Therapeutics
  • Biopharma
  • Oncology
  • Pharmaceutical
  • Health Diagnostics
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BDC Healthcare Venture frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 4
Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
Celgene
North America, New Jersey, United States, Summit
Co-Investments: 2
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 2
BDC Venture Capital
North America, Alberta, Canada, Calgary
Co-Investments: 3
CTI Life Sciences Fund
North America, Quebec, Canada, Montréal
Co-Investments: 2
Brace Pharma
North America, Maryland, United States, Rockville
Co-Investments: 1
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 1
Pappas Ventures
North America, North Carolina, United States, Durham
Co-Investments: 2

Which angels does BDC Healthcare Venture often collaborate with?

RS
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by BDC Healthcare Venture?

Repare Therapeutics

Saint Laurent, Quebec, Canada

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

BiotechnologyHealth CareOncologyPharmaceuticalTherapeutics
Series AJun 22, 2017
Amount Raised: $68,000,000
Shoebox

Ottawa, Ontario, Canada

Shoebox designs and manufactures innovative medical-grade devices and surgical equipment.

Health CareManufacturingMedical Device
Series AJan 12, 2017
Amount Raised: $6,000,000
Imagia

Montréal, Quebec, Canada

Imagia is the indispensable AI healthcare partner for pharma, medical devices and clinical providers.

AnalyticsArtificial Intelligence (AI)Health CareMedical
Series ADec 13, 2016
Amount Raised: $4,169,680
Zymeworks

Vancouver, British Columbia, Canada

Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.

BiotechnologyMedicalTherapeutics
Series AJan 8, 2016
Amount Raised: $61,500,000
Xagenic

Toronto, Ontario, Canada

Xagenic is a molecular diagnostics company developing on-demand molecular testing, facilitating faster treatment decisions for patients.

BiotechnologyHealth DiagnosticsMedical Device
Series BJul 9, 2015
Amount Raised: $11,799,698
Clementia Pharmaceuticals

Montréal, Quebec, Canada

Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders.

BiopharmaBiotechnologyMedical
Series UnknownJun 23, 2015
Amount Raised: $60,000,000
Milestone Pharmaceuticals

Montréal, Quebec, Canada

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

BiotechnologyHealth CareTherapeutics
Series BJun 15, 2015
Amount Raised: $17,000,000
Thrasos

Montréal, Quebec, Canada

Thrasos discovers and develops targeted therapies for the prevention and treatment of severe organ failures.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series DMar 31, 2015
Amount Raised: $21,000,000
Interface Biologics, Inc.

Toronto, Ontario, Canada

Interface Biologics develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices.

BiotechnologyHealth CareMedical Device
Series BJan 13, 2015
Clementia Pharmaceuticals

Montréal, Quebec, Canada

Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders.

BiopharmaBiotechnologyMedical
Series AJan 5, 2015
Amount Raised: $10,000,000